Alfons Gegenhuber

Comparison of the Biomedica NT-proBNP Enzyme Immunoassay and the Roche NT-proBNP Chemiluminescence Immunoassay: Implications for the Prediction of Symptomatic and Asymptomatic Structural Heart Disease

Thomas Mueller, Alfons Gegenhuber, Werner Poelz et al. · Clinical Chemistry · 2003 · 359 citations · Full text

Nt-probnp Split Products, Heart Failure, Immunology +16

Comparative Evaluation of B-Type Natriuretic Peptide, Mid-Regional Pro-A-type Natriuretic Peptide, Mid-Regional Pro-Adrenomedullin, and Copeptin to Predict 1-Year Mortality in Patients With Acute Destabilized Heart Failure

Alfons Gegenhuber, Joachim Struck, Benjamin Dieplinger et al. · Journal of Cardiac Failure · 2007 · 224 citations

Heart Failure, Cardiogenic Shock, Cardiovascular Disease +9

Increased Plasma Concentrations of Soluble ST2 are Predictive for 1-Year Mortality in Patients with Acute Destabilized Heart Failure

Thomas Mueller, Benjamin Dieplinger, Alfons Gegenhuber et al. · Clinical Chemistry · 2008 · 169 citations · Full text

Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease

Thomas Mueller, Alfons Gegenhuber, Werner Poelz et al. · Clinica Chimica Acta · 2004 · 154 citations

Structural Heart Disease, Cardiovascular Disease, Diagnostic Utility +8

Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples

Thomas Mueller, Alfons Gegenhuber, Benjamin Dieplinger et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2004 · 105 citations